Condition: Acute Heart Failure · Acute Coronary Syndrome · Heart Failure · Sponsor: University Hospital, Basel, Switzerland
This retrospective cohort study is to identify triggers of heart failure (HF) development and drivers of HF progression as well as the underlying cardiac disease (phenotype) to identify patients at risk and predict the clinical course of the disease. Data of patients who were hospitalized during the years 2010-2023 with acute coronary syndrome (ACS) and/ or with acute heart failure (AHF) will be collected and analyzed. In a subgroup cohort efficacy and safety of digoxin in patients with acute heart failure triggered by tachyarrhythmia will be evaluated.
This description comes directly from the study's public registry record.
Christian Müller, Prof. Dr. · 0041 6132 86 549 · Christian.mueller@usb.ch
Fiona Nafaa, MD · +41 61 32 87747 · fiona.nafaa@usb.ch
Always discuss trial participation with your own doctor first.
| Cardiology, University Hospital Basel | Basel, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04000061